Shares of Series have moved -2.2% today, and are now trading at a price of $73.63. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 1,683,431 compared to the stock's average volume of 3,747,401.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. Based in Chicago, United States the company has 53,000 full time employees and a market cap of $33,616,658,432. Series currently offers its equity investors a dividend that yields 0.1% per year.
The company is now trading -16.33% away from its average analyst target price of $88.0 per share. The 20 analysts following the stock have set target prices ranging from $73.0 to $110.0, and on average give Series a rating of buy.
Over the last 12 months GEHC shares have declined by -11.7%, which represents a difference of -28.3% when compared to the S&P 500. The stock's 52 week high is $94.8 per share and its 52 week low is $57.65. With its net margins declining an average -6.0% over the last 4 years, Series declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 19,672,000 | 1,993,000 | 10 | 25.0 |
| 2023 | 19,552,000 | 1,568,000 | 8 | -20.0 |
| 2022 | 18,341,000 | 1,916,000 | 10 | -23.08 |
| 2021 | 17,585,000 | 2,247,000 | 13 |
